Endocrinology

Top Story

Endocrinologists, urologists more likely to prescribe testosterone vs. PCPs

July 20, 2017

In the Department of Veterans Affairs health care system, prescriptions for testosterone are more likely to be written by younger providers, those with less professional experience and those in the endocrinology and urology fields compared with older providers, those with more experience and those in primary care, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

“Our study clearly shows that there is a variation in both receipt of testosterone as well as guideline-concordant prescribing of testosterone in the VA,” Guneet K. Jasuja, PhD, of the Edith Nourse Memorial Veterans Hospital in Bedford, Massachusetts, and Boston University School of Public Health, said in a press release. “Provider’s age, number of years in practice and geographic area are all associated with variations in testosterone prescribing practices.”

Meeting News

Biomarkers, CAC scoring offer advantages to predict CV risk in patients with diabetes

July 20, 2017
PHILADELPHIA — Predicting CV risk in patients with diabetes using biomarkers or imaging modalities for coronary artery calcium scoring each have their benefits…
FDA News

FDA tentatively approves second follow-on biologic insulin

July 20, 2017
The FDA has granted a tentative approval for a second follow-on biologic basal insulin in a pre-filled dosing device, Merck announced in a press release. The tentative…
In the Journals Plus

Erectile dysfunction common in diabetes

July 20, 2017
Erectile dysfunction may go undiagnosed in more than half the men with diabetes who are affected by the condition, according to results from a systematic review and…
In the Journals Plus

Biomarker predicts heart failure in type 2 diabetes

July 20, 2017
Adding N-terminal pro-B-type natriuretic peptide level to the list of traditional risk factors for heart failure substantially improved 5-year risk prediction among…
More News Headlines »
CME

Practical Lipidology®: Volume 3, Number 2

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Video
Meeting News

VIDEO: Certain antiplatelet therapies more beneficial for patients with vs. without diabetes

July 15, 2017
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

CME

Practical Lipidology®: Volume 3, Number 1

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement